Cervical Epithelial Abnormalities in Females with and without Genital Warts

Ward, Kristen M.; Lowry, Barbara E; Houston, James R.; Maw, R D

doi:10.1177/095646249400500526

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The risk of detecting HPV in the cervix was three times higher when patients had genital warts. Other studies show that women with genital warts may be at an increased risk for harboring high-risk HPV types [Moscicki et al, 2001] and have a cervical intraepithelial neoplasia risk up to six times greater [Ward et al, 1994] than women in the general population [Sellors et al, 2000] since external genital warts may be a marker of a relative deficiency in immune response [Shlay et al, 1998].…”

Section: Discussionmentioning

confidence: 99%

Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

Papachristou

Sypsa

Paraskevis

et al. 2009

Journal of Medical Virology

View full text Add to dashboard Cite

The aim of the study was to evaluate the prevalence and risk factors of HPV in a gynecological population attending outpatient clinics using two new molecular tests.The Amplicor HPV test and the Linear Array HPV Genotyping test (LA) were used for the detection of HPV DNA in 320 women. Multiple logistic regression was used to identify independent prognostic factors of HPV positivity.The agreement between the two methods in terms of their qualitative results was 89.3% (kappa: 0.63). Based on the LA results, the overall prevalence of HPV DNA was 49.1% (95% CI: 43.5%, 54.7%). The prevalence of high-risk HPV types was 30.3%. The predominant types were HPV-6 (24.8%) and HPV-16 (20.4%). Among women with normal cytology, the prevalence of HPV was much higher in those presenting other findings, such as inflammation, than those without other abnormal findings (49.5% vs. 31.5%). On the basis of multivariate analysis, the risk of HPV infection was higher among women with multiple sexual partners (>3 vs. 1: OR=3.1, 95% CI: (1.5, 7.2)), Pap smear findings (low/high-grade lesions vs. negative: OR=2.8, 95% CI: (1.2, 6.5)), the presence of warts (yes vs. no: OR=3.0, 95% CI: (1.5, 6.3)) and no history of child birth (no vs. yes: OR=2.6, 95% CI: (1.0, 6.7)). Younger age was an additional risk factor for HPV infection with carcinogenic genotypes (OR for 1-year increase =0.93, 95% CI: (0.89, 0.98)).

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

Papachristou

Sypsa

Paraskevis

et al. 2009

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…Although previous studies have evaluated psychosocial issues in patients with genital warts (Ward, Lowry, Houston, & Maw, 1994; Chandler, 1996), few have asked specifically about HPV. One study of women attending a well woman clinic in London found that subjects with a history of genital warts were more likely to have heard about HPV, but this study did not report on other HPV knowledge questions for this subgroup (Waller, McCaffery, Forrest, Szarewski, Cadman, & Wardle, 2003).…”

Section: Introductionmentioning

confidence: 99%

Knowledge of Human Papillomavirus: Differences by Self-Reported Treatment for Genital Warts and Sociodemographic Characteristics

Koshiol

Rutten

Moser

et al. 2009

Journal of Health Communication

View full text Add to dashboard Cite

The aim of this study was to evaluate knowledge about human papillomavirus (HPV) in individuals with genital warts compared to women from the general population without genital warts. HPV knowledge among women reporting treatment for genital warts was compared to HPV knowledge in women reporting no treatment was assessed using data from the population-based 2005 Health Information National Trends Survey. Three percent (N=97) of women answered "yes" and 97% (N=3450) "no" to "Have you ever been treated for venereal warts or condyloma?" Women who reported treatment for genital warts were more likely to have heard of HPV (Odds ratio (OR): 2.4, 95% confidence interval (CI): 1.4-4.2 vs. no or don't know), to have been told they had HPV (OR: 24.5, 95% CI: 11.4-52.8), and to have accurate information about HPV, such as HPV causes cancer (OR: 2.7, 95% CI: 1.8-4.3). However, a large proportion (41%) of women who reported treatment for genital warts had not heard of HPV. These women tended to be older, poorer, less educated, nonHispanic black, less likely to have had a recent Pap test, and divorced, widowed, or separated. Women with genital warts are learning about HPV, but socioeconomically disadvantaged groups may need to be targeted.

show abstract

Cervical Epithelial Abnormalities in Females with and without Genital Warts

Cited by 2 publications

References 4 publications

Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

Knowledge of Human Papillomavirus: Differences by Self-Reported Treatment for Genital Warts and Sociodemographic Characteristics

Contact Info

Product

Resources

About